FibroGen (FGEN) Tops Q3 EPS by 3c

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.65), $0.03 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $40.1 million versus the consensus estimate of $36.84 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Doximity downgraded by BofA on AI investment concerns, margin pressure
• Hormel Foods agrees to sell Brazil's Ceratti brand to Zanchetta